iAnthus Capital Holdings stock analysis
Want to see TSE:IAN full AI Analyst Report?
iAnthus Capital Holdings (IAN) Stock Price & Analysis
IAN Stock Chart & Stats
- Day’s Range
- CAD 0.01 - CAD 0.01
- 52-Week Range
- CAD 0.01 - CAD 0.02
- Previous Close
- CAD 0.01
- Volume
- N/A
- Average Volume (3M)
- 144.26K
- Market Cap
- CAD 34.87M
- Enterprise Value
- CAD 371.90M
- Total Cash (Recent Filing)
- CAD 8.26M
- Total Debt (Recent Filing)
- CAD 238.68M
- Price to Earnings (P/E)
- ―
- Beta
- -2.58
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Licensed Cannabis Platform
The company has historically operated across multiple licensed cannabis activities, providing vertical capabilities from cultivation through retail. This platform can support product control and market access if restructuring restores operational continuity.
Positive Gross Margin
A positive gross margin indicates the core products still generate contribution before operating costs, while the improvement versus 2025 suggests some underlying economics remain viable. Sustaining this margin could aid recovery if revenue stabilizes.
Established Operating Footprint
The workforce and historical multi-function presence indicate an established operating platform rather than a purely prospective business. That infrastructure may provide useful capabilities for rebuilding operations, though execution remains dependent on financial stabilization.
Bears Say
Severe Revenue Contraction
A sharp and sustained top-line decline weakens operating leverage, reduces the company’s ability to absorb fixed costs, and can erode market presence. Recovery would require renewed demand, stable operations, and successful execution across its regulated markets.
Persistent Unprofitability
Deep losses and negative operating profit show that gross profit is not covering the broader cost base. Unless management materially improves scale, expenses, or pricing, the business is likely to remain dependent on external funding.
Stressed Balance Sheet And Cash Burn
Negative equity, high debt relative to assets, and materially negative free cash flow leave limited financial flexibility. This combination raises refinancing and solvency risk while increasing the need for capital or restructuring to sustain operations.
IAN FAQ
What was iAnthus Capital Holdings’s price range in the past 12 months?
What is iAnthus Capital Holdings’s market cap?
When is iAnthus Capital Holdings’s upcoming earnings report date?
How were iAnthus Capital Holdings’s earnings last quarter?
Is iAnthus Capital Holdings overvalued?
Does iAnthus Capital Holdings pay dividends?
What is iAnthus Capital Holdings’s EPS estimate?
How many shares outstanding does iAnthus Capital Holdings have?
What happened to iAnthus Capital Holdings’s price movement after its last earnings report?
Which hedge fund is a major shareholder of iAnthus Capital Holdings?
What is the TipRanks Smart Score and how is it calculated?
Company Description
iAnthus Capital Holdings
iAnthus Capital Holdings, Inc. is a U.S.-based cannabis enterprise that holds licenses for and actively manages cannabis cultivation, processing, and retail dispensary operations. Its diverse product portfolio encompasses both cannabis and cannabidiol (CBD) offerings. For cannabis, these include traditional biomass items like pre-rolls, various infused products such as edibles and topical creams, and a wide array of concentrates and vapeables, specifically live resins, waxes, oils, tinctures, and vape cartridges. The CBD line features topical creams, tinctures, and sprays, alongside a comprehensive range of beauty and skincare solutions, including lotions, haircare items, lip balms, and bath bombs. Beyond direct retail, the company also engages in wholesale distribution of its CBD product selection. Operationally, iAnthus maintains a significant presence, controlling or operating 32 retail dispensaries and 10 cultivation or processing facilities across eight states. Established in 2014, its corporate headquarters are located in New York, New York.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Richard Proud
- Employees
- 741
- Website
- www.ianthus.com
- Address
- 214 King Street West, Toronto, ON, M5H 3S6, CA
iAnthus Capital Holdings (IAN) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 2 | 3 | 11 |
| Technical Analysis | 1 | 2 | 5 |
| Moving Averages | 1 | 1 | 6 |












